MSKCC Nomogram: Probability of organ-confined disease in prostate cancer patients (includes biopsy cores)
Calculates the probability that the cancer will be found to be confined to the prostate gland when the prostate is removed (c-index: 0.71). This model includes biopsy cores. 

Disqualifying treatments: This model does not apply to patients who underwent preoperative hormone- or radiation therapy for prostate cancer. 
Research authors: Source: Memorial Sloan Kettering Cancer Center (US)
Version: 2.8
  • Details
  • Validate model
  • Save input
  • Load input

Calculate the result

Set more parameters to perform the calculation

Probability of organ-confined disease:

{{ resultSubheader }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

How this model should be used:
This model calculates the probability that the cancer will be found to be confined to the prostate gland when the prostate is removed. This model does not apply to patients who underwent preoperative hormone- or radiation therapy for prostate cancer. 

Result interpretation: 
A low probability of organ-confined disease does not necessarily mean that surgery cannot cure the cancer. About 50 percent of patients who do not have organ-confined cancer have long-term freedom from recurrence following surgery. The probability of having organ-confined prostate cancer is not equal to the probability that surgery will provide long-term freedom from recurrence, because the cancer does not have to be organ confined to be successfully treated with surgery.

Model performance: 
A validation was performed to assess the discriminative power of the model. On the website of the MSKCC, a c-index of 0.71 is reported. No specific details regarding the validation process are disclosed.

Alternative models: 
For cases in which the number of cores taken at biopsy is unknown, an alternative prediction model that does not require this information is available. This alternative model provides slightly less refined predictions (c-index 0.67 versus 0.71, respectively).


Source: Memorial Sloan Kettering Cancer Center.

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This model is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying models Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}


Evidencio Community Account Benefits


With an Evidencio Community account you can:

  • Create and publish your own prediction models.
  • Share your prediction models with your colleagues, research group, organization or the world.
  • Review and provide feedback on models that have been shared with you.
  • Validate your models and validate models from other users.
  • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction models and their data.
  • Use patient specific protocols and guidelines based on sequential models and decision trees.
  • Stay up-to-date with new models in your field as they are published.
  • Create your own lists of favorite models and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.


Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Evidencio v3.25 © 2015 - 2024 Evidencio. All Rights Reserved